The management of lupus nephritis as proposed by EULAR/ERA 2019 versus KDIGO 2021

Hans-Joachim Anders1, Jerome Loutan1, Annette Bruchfeld2,3

  • 1Division of Nephrology, Medizinische Klinik und Poliklinik IV, Klinikum der Universität, Munich, Germany.

Insights

The European League for Rheumatism (EULAR) and Kidney Disease: Improving Global Outcomes (KDIGO) released updated lupus nephritis (LN) guidelines. While mostly consistent, key differences exist in managing lupus podocytopathies and specific treatment scenarios.

Area of Science:

  • Nephrology
  • Rheumatology
  • Immunology

Background:

  • Updated lupus nephritis (LN) management guidelines were released in 2019 by EULAR/ERA and in 2021 by KDIGO.
  • These guidelines address the increasing complexity of managing LN, a significant autoimmune kidney disease.

Purpose of the Study:

  • To review and compare the 2019 EULAR/ERA and 2021 KDIGO guidelines for lupus nephritis management.
  • To identify and clarify discrepancies between the two sets of guidelines to aid clinical practice.

Main Methods:

  • Comparative analysis of recommendations from the EULAR/ERA (2019) and KDIGO (2021) lupus nephritis guidelines.
  • Focus on areas of consistency, negligible differences, and relevant distinctions in management strategies.

Main Results:

  • High consistency observed in recommendations for kidney biopsy indications, interpretation, treatment targets, hydroxychloroquine dosing, initial therapy for active LN, and management in pregnancy, pediatrics, and kidney failure.
  • Key differences identified in the recognition of lupus podocytopathies, steroid dosing, drug preferences, maintenance therapy, treatment of pure class V LN, recurrent LN, alternative drug options, and thrombotic microangiopathy work-up.

Conclusions:

  • Both guideline documents offer excellent guidance for lupus nephritis management.
  • Clarifying the identified differences is crucial to prevent confusion and ensure optimal patient care in complex LN cases.

Related Concept Videos

Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
63
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
104
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
35
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
80
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
68
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
109